Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03022903 · ClinicalTrials.gov registry record · NA
Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03022903 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 2 participants.
The verdict
NCT03022903, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This research study will evaluate the safety and efficacy of using blue light photodynamic therapy (PDT) for treating toenail fungal infections.
Interventions
- PROCEDURE Aminolevulinic Acid (ALA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-09 |
| Est. Completion | 2021-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03022903
The ClinicalTrials.gov registry entry for NCT03022903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aminolevulinic Acid (ALA) is the first listed.
NCT03022903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03022903 about?
NCT03022903 is a clinical study titled "Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis". This research study will evaluate the safety and efficacy of using blue light photodynamic therapy (PDT) for treating toenail fungal infections.
What is the current status of trial NCT03022903?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2015-09. Estimated completion is 2021-12.
What interventions are being tested in trial NCT03022903?
The interventions under investigation include: Aminolevulinic Acid (ALA) (PROCEDURE).
Who is sponsoring clinical trial NCT03022903?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.